Catalyst

Slingshot members are tracking this event:

Phase 2a PET interim data of Pliant Therapeutics' (PLRX) PLN-74809 Idiopathic pulmonary fibrosis to be released September 7, 2021

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
PLRX Community voting in process
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Pln-74809, Idiopathic Pulmonary Fibrosis